Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

INTRODUCTION: PROWESS (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis) was a phase III, randomized, double blind, placebo controlled, multicenter trial conducted in patients with severe sepsis from 164 medical centers. Here we report data collected at study entry for 169...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinasewitz, Gary T, Yan, S Betty, Basson, Bruce, Comp, Philip, Russell, James A, Cariou, Alain, Um, Suzane L, Utterback, Barbara, Laterre, Pierre-Francois, Dhainaut, Jean-François
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420030/
https://www.ncbi.nlm.nih.gov/pubmed/15025782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420030/
https://www.ncbi.nlm.nih.gov/pubmed/15025782

Ejemplares similares